SE9703407D0 - New use - Google Patents

New use

Info

Publication number
SE9703407D0
SE9703407D0 SE9703407A SE9703407A SE9703407D0 SE 9703407 D0 SE9703407 D0 SE 9703407D0 SE 9703407 A SE9703407 A SE 9703407A SE 9703407 A SE9703407 A SE 9703407A SE 9703407 D0 SE9703407 D0 SE 9703407D0
Authority
SE
Sweden
Prior art keywords
new use
formoterol
budesonide
relates
new
Prior art date
Application number
SE9703407A
Other languages
English (en)
Swedish (sv)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9703407(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9703407A priority Critical patent/SE9703407D0/xx
Publication of SE9703407D0 publication Critical patent/SE9703407D0/xx
Priority to SI9830844T priority patent/SI1210943T1/sl
Priority to TR2000/00726T priority patent/TR200000726T2/xx
Priority to CA2302700A priority patent/CA2302700C/en
Priority to BR9812325-4A priority patent/BR9812325A/pt
Priority to KR1020007002900A priority patent/KR20010024140A/ko
Priority to MXPA00002615A priority patent/MXPA00002615A/es
Priority to EP98944373A priority patent/EP1014993B1/en
Priority to DK02001670T priority patent/DK1210943T3/da
Priority to IDW20000506A priority patent/ID24838A/id
Priority to ES98944373T priority patent/ES2182357T3/es
Priority to AU91928/98A priority patent/AU757235B2/en
Priority to EP02001670A priority patent/EP1210943B1/en
Priority to DE69807239T priority patent/DE69807239T2/de
Priority to HU0003848A priority patent/HUP0003848A2/hu
Priority to PT02001670T priority patent/PT1210943E/pt
Priority to ES02001670T priority patent/ES2266322T3/es
Priority to DE69834955T priority patent/DE69834955T2/de
Priority to PCT/SE1998/001599 priority patent/WO1999015182A1/en
Priority to CZ2000950A priority patent/CZ295250B6/cs
Priority to EEP200000145A priority patent/EE04297B1/xx
Priority to PL339295A priority patent/PL190782B1/pl
Priority to SK389-2000A priority patent/SK285330B6/sk
Priority to IL13477398A priority patent/IL134773A/xx
Priority to AT98944373T priority patent/ATE222106T1/de
Priority to NZ503173A priority patent/NZ503173A/en
Priority to UA2000031372A priority patent/UA72446C2/ru
Priority to DK98944373T priority patent/DK1014993T3/da
Priority to SI9830272T priority patent/SI1014993T1/xx
Priority to PT98944373T priority patent/PT1014993E/pt
Priority to CNB988093103A priority patent/CN1149998C/zh
Priority to JP2000512551A priority patent/JP2001517630A/ja
Priority to AT02001670T priority patent/ATE329599T1/de
Priority to RU2000106597/14A priority patent/RU2199322C2/ru
Priority to IN2781DE1998 priority patent/IN190791B/en
Priority to TW087115428A priority patent/TW546140B/zh
Priority to ZA988516A priority patent/ZA988516B/xx
Priority to ARP980104682A priority patent/AR013506A1/es
Priority to MYPI98004288A priority patent/MY127812A/en
Priority to SA98190773A priority patent/SA98190773B1/ar
Priority to IS5407A priority patent/IS2715B/is
Priority to NO20001401A priority patent/NO327176B1/no
Priority to US10/010,283 priority patent/US7897646B2/en
Priority to HK02107290.0A priority patent/HK1045812B/zh
Priority to CY20061101297T priority patent/CY1106156T1/el
Priority to US12/982,360 priority patent/US8461211B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9703407A 1997-09-19 1997-09-19 New use SE9703407D0 (sv)

Priority Applications (46)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use
AT02001670T ATE329599T1 (de) 1997-09-19 1998-09-09 Neue verwendung von budesonide und formoterol
TR2000/00726T TR200000726T2 (tr) 1997-09-19 1998-09-09 Budesonid ve formoterol'ün yeni kullanımı.
PL339295A PL190782B1 (pl) 1997-09-19 1998-09-09 Nowe zastosowanie budesonidu i formoterolu
AT98944373T ATE222106T1 (de) 1997-09-19 1998-09-09 Neue verwendung von budesonide und formoterol
CA2302700A CA2302700C (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol
IL13477398A IL134773A (en) 1997-09-19 1998-09-09 Use for budesonide and formoterol
KR1020007002900A KR20010024140A (ko) 1997-09-19 1998-09-09 부데소니드 및 포르모테롤에 대한 신규 용도
MXPA00002615A MXPA00002615A (es) 1997-09-19 1998-09-09 Uso novedoso para la budesonida y el formoterol.
EP98944373A EP1014993B1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol
DK02001670T DK1210943T3 (da) 1997-09-19 1998-09-09 Ny anvendelse af budesonid og formoterol
IDW20000506A ID24838A (id) 1997-09-19 1998-09-09 Penggunaan untuk beudesonid dan formoterol
ES98944373T ES2182357T3 (es) 1997-09-19 1998-09-09 Nueva utilizacion de budesonide y formoterol.
AU91928/98A AU757235B2 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol
EP02001670A EP1210943B1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol
DE69807239T DE69807239T2 (de) 1997-09-19 1998-09-09 Neue verwendung von budesonide und formoterol
HU0003848A HUP0003848A2 (hu) 1997-09-19 1998-09-09 Budesonid és formoterol új alkalmazása
PT02001670T PT1210943E (pt) 1997-09-19 1998-09-09 Nova utilizacao para budesonida e formoterol
ES02001670T ES2266322T3 (es) 1997-09-19 1998-09-09 Nuevo uso de budesonida y formoterol.
DE69834955T DE69834955T2 (de) 1997-09-19 1998-09-09 Neue Verwendung von Budesonide und Formoterol
NZ503173A NZ503173A (en) 1997-09-19 1998-09-09 Use of a combination of budesonide and formoterol to treat chronic obstructive pulmonary disease (COPD)
CZ2000950A CZ295250B6 (cs) 1997-09-19 1998-09-09 Farmaceutické prostředky s obsahem formoterolu a budesonidu k léčení chronické obstrukční choroby plicní
EEP200000145A EE04297B1 (et) 1997-09-19 1998-09-09 Budesoniidi ja formoterooli uus kasutamine
SI9830844T SI1210943T1 (sl) 1997-09-19 1998-09-09 Nova uporaba za budesonid in formoterol
SK389-2000A SK285330B6 (sk) 1997-09-19 1998-09-09 Použitie formoterolu a budesonidu na výrobu farmaceutického prostriedku na liečbu chronickej obštrukčnej pľúcnej choroby
BR9812325-4A BR9812325A (pt) 1997-09-19 1998-09-09 Novo uso para budesonida e formoterol
RU2000106597/14A RU2199322C2 (ru) 1997-09-19 1998-09-09 Новое применение будезонида и формотерола
PCT/SE1998/001599 WO1999015182A1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol
UA2000031372A UA72446C2 (ru) 1997-09-19 1998-09-09 Новое применение формотерола и будезонида
DK98944373T DK1014993T3 (da) 1997-09-19 1998-09-09 Hidtil ukendt anvendelse af budesonid og formoterol
SI9830272T SI1014993T1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol
PT98944373T PT1014993E (pt) 1997-09-19 1998-09-09 Nova utilizacao de budenosido e formoterol
CNB988093103A CN1149998C (zh) 1997-09-19 1998-09-09 布地奈德和福莫特罗的新用途
JP2000512551A JP2001517630A (ja) 1997-09-19 1998-09-09 ブデソニドおよびホルモテロールの新たな使用
TW087115428A TW546140B (en) 1997-09-19 1998-09-16 Pharmaceutical composition for use in the treatment of chronic obstructive pulmonary disease
IN2781DE1998 IN190791B (ru) 1997-09-19 1998-09-16
ZA988516A ZA988516B (en) 1997-09-19 1998-09-17 New use for budesonide and formoterol
ARP980104682A AR013506A1 (es) 1997-09-19 1998-09-18 Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
MYPI98004288A MY127812A (en) 1997-09-19 1998-09-18 New use for budesonide and formoterol
SA98190773A SA98190773B1 (ar) 1997-09-19 1998-11-18 استخدام جديد لبيوديسونيد budesonide وفورموتيرول formoterol
IS5407A IS2715B (is) 1997-09-19 2000-03-15 Ný notkun fyrir búdesóníð og formóteról
NO20001401A NO327176B1 (no) 1997-09-19 2000-03-17 Ny anvendelse for budesonid og formoterol
US10/010,283 US7897646B2 (en) 1997-09-19 2001-11-13 Use for budesonide and formoterol
HK02107290.0A HK1045812B (zh) 1997-09-19 2002-10-03 布地縮鬆和福莫特羅的新用途
CY20061101297T CY1106156T1 (el) 1997-09-19 2006-09-12 Νεα χρηση βουδεσονιδης και φορμοτepολης
US12/982,360 US8461211B2 (en) 1997-09-19 2010-12-30 Use for budesonide and formoterol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use

Publications (1)

Publication Number Publication Date
SE9703407D0 true SE9703407D0 (sv) 1997-09-19

Family

ID=20408325

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use

Country Status (38)

Country Link
US (2) US7897646B2 (ru)
EP (2) EP1014993B1 (ru)
JP (1) JP2001517630A (ru)
KR (1) KR20010024140A (ru)
CN (1) CN1149998C (ru)
AR (1) AR013506A1 (ru)
AT (2) ATE222106T1 (ru)
AU (1) AU757235B2 (ru)
BR (1) BR9812325A (ru)
CA (1) CA2302700C (ru)
CY (1) CY1106156T1 (ru)
CZ (1) CZ295250B6 (ru)
DE (2) DE69807239T2 (ru)
DK (2) DK1014993T3 (ru)
EE (1) EE04297B1 (ru)
ES (2) ES2266322T3 (ru)
HK (1) HK1045812B (ru)
HU (1) HUP0003848A2 (ru)
ID (1) ID24838A (ru)
IL (1) IL134773A (ru)
IN (1) IN190791B (ru)
IS (1) IS2715B (ru)
MX (1) MXPA00002615A (ru)
MY (1) MY127812A (ru)
NO (1) NO327176B1 (ru)
NZ (1) NZ503173A (ru)
PL (1) PL190782B1 (ru)
PT (2) PT1014993E (ru)
RU (1) RU2199322C2 (ru)
SA (1) SA98190773B1 (ru)
SE (1) SE9703407D0 (ru)
SI (2) SI1210943T1 (ru)
SK (1) SK285330B6 (ru)
TR (1) TR200000726T2 (ru)
TW (1) TW546140B (ru)
UA (1) UA72446C2 (ru)
WO (1) WO1999015182A1 (ru)
ZA (1) ZA988516B (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
CZ303154B6 (cs) * 1998-11-13 2012-05-09 Jagotec Ag Suchá prášková formulace k inhalaci obsahující stearát horecnatý
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
BR0207062A (pt) * 2001-02-06 2004-10-05 Innovata Biomed Ltd Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
CN1694689A (zh) * 2002-09-30 2005-11-09 阿库斯菲尔公司 供吸入的缓释多孔微粒
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2007011743A2 (en) 2005-07-14 2007-01-25 Lipothera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
JP2009519970A (ja) * 2005-12-15 2009-05-21 アキュスフィア， インコーポレイテッド 粒子ベースの経口投与用製薬剤形の製造方法
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2010253776B2 (en) 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
US20110132355A1 (en) * 2009-06-09 2011-06-09 William Gerhart Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
SG182485A1 (en) * 2010-01-15 2012-08-30 Lithera Inc Lyophilized cake formulations
CN103269693A (zh) 2010-11-24 2013-08-28 利赛拉公司 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
BR112018011266B1 (pt) 2015-12-04 2023-11-21 Mexichem Fluor S.A. De C.V. Composição farmacêutica, recipiente vedado, e, métodos para tratar um paciente que sofre ou é propenso a sofrer de um distúrbio respiratório e para estabilizar uma composição farmacêutica
JP7470646B2 (ja) 2018-06-14 2024-04-18 アストラゼネカ・ユーケイ・リミテッド コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
CA2024872C (en) 1989-09-08 2002-07-09 James Barry Douglas Palmer Medicaments
US5250286A (en) 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
EP1101493A3 (en) 1991-12-18 2004-01-14 AstraZeneca AB New combination of formoterol and budesonide
WO1993011773A1 (en) 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
TR199800924T2 (xx) * 1995-11-24 1998-08-21 Smithkline Beecham S.P.A. Quinoline t�revleri.
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CA2295076A1 (en) 1997-06-27 1999-01-07 Astra Aktiebolag New combination of antiasthma medicaments
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
CZ295250B6 (cs) 2005-06-15
PT1210943E (pt) 2006-09-29
DK1014993T3 (da) 2002-11-11
DE69834955D1 (de) 2006-07-27
ATE222106T1 (de) 2002-08-15
ATE329599T1 (de) 2006-07-15
PL339295A1 (en) 2000-12-04
EE200000145A (et) 2001-02-15
CN1271287A (zh) 2000-10-25
IS5407A (is) 2000-03-15
ES2266322T3 (es) 2007-03-01
US20060189587A9 (en) 2006-08-24
IN190791B (ru) 2003-08-23
DE69807239D1 (de) 2002-09-19
JP2001517630A (ja) 2001-10-09
TW546140B (en) 2003-08-11
US7897646B2 (en) 2011-03-01
CN1149998C (zh) 2004-05-19
PL190782B1 (pl) 2006-01-31
SK285330B6 (sk) 2006-11-03
HUP0003848A2 (hu) 2001-08-28
NO327176B1 (no) 2009-05-04
SA98190773B1 (ar) 2006-10-02
AU9192898A (en) 1999-04-12
EP1014993B1 (en) 2002-08-14
HK1045812B (zh) 2006-12-22
NO20001401L (no) 2000-03-17
IS2715B (is) 2011-02-15
DK1210943T3 (da) 2006-09-18
DE69834955T2 (de) 2007-01-25
HK1045812A1 (en) 2002-12-13
NO20001401D0 (no) 2000-03-17
NZ503173A (en) 2001-08-31
SK3892000A3 (en) 2000-12-11
BR9812325A (pt) 2000-09-05
WO1999015182A1 (en) 1999-04-01
SI1014993T1 (en) 2003-02-28
CY1106156T1 (el) 2011-06-08
EP1014993A1 (en) 2000-07-05
US20110097282A1 (en) 2011-04-28
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
PT1014993E (pt) 2002-12-31
TR200000726T2 (tr) 2000-09-21
EE04297B1 (et) 2004-06-15
EP1210943B1 (en) 2006-06-14
DE69807239T2 (de) 2003-04-10
MY127812A (en) 2006-12-29
ES2182357T3 (es) 2003-03-01
MXPA00002615A (es) 2002-04-24
AU757235B2 (en) 2003-02-06
AR013506A1 (es) 2000-12-27
IL134773A (en) 2005-03-20
EP1210943A1 (en) 2002-06-05
UA72446C2 (ru) 2005-03-15
IL134773A0 (en) 2001-04-30
US8461211B2 (en) 2013-06-11
ZA988516B (en) 1999-03-19
ID24838A (id) 2000-08-24
CA2302700C (en) 2010-11-23
CZ2000950A3 (cs) 2000-06-14
SI1210943T1 (sl) 2006-10-31
CA2302700A1 (en) 1999-04-01
US20020042404A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
SE9703407D0 (sv) New use
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE60010662D1 (de) Kombinationen von formoterol und fluticasonpropionat für asthma
DE69838728D1 (de) Methoden und zusammensetzungen zum wirksameren abfangen von sauerstoff
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
DE69528011D1 (de) Verfahren zur Pflege der Nägel
EE9900036A (et) Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks
DE69500727D1 (de) Klebstoffmischung und Faser-Gummi-Verbundwerkstoff
FI965204A (fi) Bromelaiinin lääkekäyttö
ITMI951759A0 (it) Procedimento e dispositivo per il trattamento di materiali
FI961380A (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
ATE227130T1 (de) 5-alpha-pregnan-3-beta-ol-20-one 3-sulfate für di behandlung von tumoren und zns krankheiten
NO991158L (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
DE69316179D1 (de) Anordnung bestehend aus Flansch und Auskleidung zum Sanieren von Rohrleitungen
NO964291D0 (no) Fremgangsmåte for behandling av allergisk rinitt
DE69833655D1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
UA25095A (uk) Ліhімеhт для лікуваhhя каhдидозhого і змішаhого вульвовагіhіту
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID16159A (id) Komposisi dan metode untuk mengobati gangguan pernafasan